🔎 Trials Near Me

Home › Idiopathic Pulmonary Fibrosis › Virginia

Idiopathic Pulmonary Fibrosis clinical trials in Virginia

8 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Virginia.

Cities in Virginia

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

  • Inova Healthcare, Falls Church
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

  • Research Site, Richmond
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 21, 2026 · NCT07652658

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • UVA Center for Psychiatric Clinical Research, Charlottesville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

  • Pulmonary Associates of Richmond Inc (Par) - West Broad Location, Richmond
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 14, 2026 · NCT07671911

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

  • Inova Fairfax Hospital /ID# 278469, Falls Church
  • Virginia Commonwealth University Medical Center /ID# 277992, Richmond
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 3, 2026 · NCT07230288

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • Inova, Falls Church
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511

Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

  • Snyder Building 480 Ray C. Hunt Drive, Charlottesville
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jul 9, 2025 · NCT06853145

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

  • University of Virginia, Charlottesville
RecruitingObservational study
Ages 40 to 101 · All sexes · Updated Aug 16, 2024 · NCT06323876

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.